The regulator found some drugs as "not of standard quality", including a batch each of Alkem Laboratories' popular ... and several antibiotics, according to the lists for August.

Researchers say they have discovered a new class of antibiotics that could treat drug-resistant bacteria, the first to reach the market in nearly three decades. The new molecule, called ...

A virulent strain of antibiotic-resistant ‘superbug’ bacteria that causes severe disease has been found circulating in a Malaysian hospital, a new study by academics has revealed. The threat ...

Solara Active Pharma Sciences, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹537.95. The stock has experienced fluctuations ...

Mumbai: Alkem Labs has announced the retirement of Adil Billimoria, Senior Management Personnel of the Company. "We wish to inform you that Mr. Adil Billimoria, Senior Management Personnel of the ...

Alkem Laboratories Ltd. is a Public Limited Listed company incorporated on 08/08/1973 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) ...

Alkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 57,734.35 Crore) operating in Pharmaceuticals sector. Alkem Laboratories Ltd. key ...

Headquartered in Mumbai India Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development manufacture and sale of ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Antimicrobial resistance is the ability of microorganisms such as bacteria, fungi or protozoans to grow despite exposure to antimicrobial substances designed to inhibit their growth. Microbes can ...